Diabetics are allowed if:\r\n* Fasting blood glucose (FBG) =< 130 mg/dL (mmol/L),\r\nOR\r\n* HbA1c =< 7%
Fasting glucose =< 126 mg/dL (7.0 mmol/L)
Fasting plasma glucose < 140 mg/dL/7.8 mmol/L
Fasting glucose under control (< 150 mg/dL [8.3 mmol/L])
Fasting plasma glucose < 140 mg/dL / 7.7 mmol/L and glycosylated hemoglobin (HbA1c) =< 8% (both criteria have to be met)
Fasting plasma glucose (FPG) =< 160 mg/dL or 7.8 mmol/L
Fasting plasma glucose =< 200 mg/dL
Fasting plasma glucose =< 175 mg/dL (=< 9.8 mmol/L)
Fasting plasma glucose =< 175 mg/dL (=< 9.8 mmol/L)
CERITINIB INCLUSION CRITERIA: Fasting plasma glucose =< 175 mg/dL (=< 9.8 mmol/L)
Fasting plasma glucose =< 175 mg/dL (=< 9.8 mmol/L)
For patients without known type II diabetes, the following is required at screening:\r\n* Fasting plasma glucose =< 160 mg/dL (7.49 mmol/L) and glycosylated hemoglobin (HbA1c) < 7.5 % or International Federation of Clinical Chemistry (IFCC) < 53 mmol/mol
Fasting plasma glucose =< 175 mg/dL (=< 9.8 mmol/L)
Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L)
Known diabetes (type 1 or 2), fasting glucose > or equal to 7.0 mmol/L (126 mg/dL), or HgbA1C > 6.5
Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L) (Gedatolisib can cause hyperglycemia)
Fasting plasma glucose =< 120 mg/dL
Fasting plasma glucose (FPG) =< 140 mg/dL or =< 7.8 mmol/L
Fasting plasma glucose (FPG) =< 140mg/dL or =< 7.8 mmol/L
Patient has fasting plasma glucose (FPG) ?140 mg/dL (7.7 mmol/L) and glycosylated hemoglobin (HbA1c) ? 6.4% (both criteria have to be met)
Glucose < 40 mg/dl (< 2.2 mmol/L) or > 250 mg/dl (> 14mmol/L)
Glucose < 40 mg/dl (< 2.2 mmol/L) or > 250 mg/dl (> 14 mmol/L)
Subjects with fasting plasma glucose ? 125 mg/dL and HbA1c < 6.5 % at screening\n             Subjects with fasting plasma glucose ?150 mg/dL and HbA1c ? 7.0 % at screening for\n             the Diabetes Expansion Cohort.
Within 14 days of subject registration: Fasting plasma glucose =< 140 mg/dL or 7.8 mmol/L\r\n* (NOTE: Fasting whole blood glucose testing is acceptable if fasting plasma glucose is not feasible)
Fasting plasma glucose (FPG) =< 140 mg/dL
Fasting serum glucose < 126 mg/dl (7 mmol/l)
Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L)
Fasting plasma glucose < 8.9 mmol/L (< 160 mg/dL) and HbA1c < 8.0%. Inclusion criteria only for patients entering phase Ib escalation and phase II:
Grade ?2 hypercholesterolemia (TC >300 mg/dL or >7.75 mmol/L) and/or hypertriglyceridemia (TG >300 mg/dL or >3.42 mmol/L) in the fasting state.
Fasting plasma glucose (FPG) =< 120 mg/dL or =< 6.7 mmol/L
Baseline fasting glucose of < 126 mg/dl (7 mmol/L)
Known diabetes (type 1 or 2) or baseline fasting glucose >= 126 mg/dl (7 mmol/L)
Fasting plasma glucose (FPG) < 140 mg/dL/7.8 mmol/L, where fasting is defined as no food intake for 8 hours prior to measurement
Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L)
At least 4 weeks (28 days) prior to registration: Fasting plasma glucose (FPG) < 140 mg/dL/7.8 mmol/L
Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L), if not consider initiation of metformin treatment prior to study treatment
Obtained within 2 weeks from study entry: Fasting plasma glucose =< 140 mg/dL
ARM A: Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L); ARM B: Fasting plasma glucose =< 140 mg/dL (7.8 mmol/L); hemoglobin A1c (HbA1c) =< 8%; ARMS C and D: Fasting plasma glucose =< 150 mg/dL
Fasting blood glucose of ? 140 mg/dL (7.8 mmol/L).
Fasting blood glucose of ? 140 mg/dL (7.8 mmol/L).
Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L)
Patients with diabetes mellitus requiring insulin treatment and/or with clinical signs or with Fasting Plasma Glucose (FPG) ? 140 mg/dL / 7.8 mmol/L
Fasting plasma glucose > 120mg/dL or > 6.7 mmol/L
Fasting glucose of ?126 mg/dL (7.0 mmol/L).
Fasting plasma glucose =< 175 mg/dL (=< 9.8 mmol/L)
Glycated hemoglobin (HgbA1c) ? 7 %; Fasting Plasma Glucose (FPG) ? 7.0 mmol/L (125 mg/dL).
Fasting glucose > 7.0 mmol/L (126 mg/dL). or HbA1c > 6.4%.
Fasting glucose < 140 mg/dL (7.8 mmol/L).
Fasting plasma glucose < 8.9 mmol/L (< 160mg/dL) and HbA1C < 8%
Fasting plasma glucose (FPG) ? 120 mg/dL or ? 6.7 mmol/L
Fasting plasma glucose =< 120 mg/dL (6.7 mmol/L)
Fasting plasma glucose (FPG) =< 120 mg/dL or 6.7 mmol/L
Fasting plasma glucose =< 175 mg/dL (=< 9.8 mmol/L) - if glucose is checked in the non fasting state and it is =< 175 mg/dL then this will be acceptable
Fasting plasma glucose < 120 mg/dL
Fasting glucose < grade 2 (=< 160 mg/dL or =< 8.9 mmol/L) without the use of antihyperglycemic agents
Fasting plasma glucose =< 130 mg/dL (or 7.2 mmol/L)
Patients with a history of or known diagnosis of diabetes according to national guidelines (fasting plasma glucose >= 126 mg/dL or random plasma glucose >= 200 mg/dL), as evidenced in laboratory values =< 3 months old
Fasting plasma glucose < 140 mg/dL/7.7 mmol/L
12 hour fasting glucose level < 7.0 mmol/L
No known diabetes (type 1 or 2) or baseline fasting glucose >= 7.0 mmol/L
Plasma glucose =< 200 mg/dL
Plasma glucose > 200 mg/dL
